UNFUCG
DashboardSearchChatBookmarksNotificationsActivityPremiumProfile
?
Home
Search
Chat
Saved
Profile
Episode
Brian Armstrong on Bitcoin, Anthropic Drops Fable 5 & Mythos 5, NewLimit's $435M Age-Reversal | 264
~145 min
Episode Brief·YouTube

Brian Armstrong on Bitcoin, Anthropic Drops Fable 5 & Mythos 5, NewLimit's $435M Age-Reversal | 264

Peter Diamandis
Watch on YouTube Add to chat My bookmarks← All sources

TL;DR

The four things you'd lose by not watching

4 items

TL;DR

The four things you'd lose by not watching

4 items
1

Brian Armstrong sees Bitcoin as 'digital gold' and believes the recent price dip is temporary, driven by AI absorbing risk capital and stablecoins becoming the 'new meta'; he's bullish long-term.

2

Anthropic launched Fable 5 and Mythos 5, retaking the AI frontier lead with models demonstrating long-range reasoning, including playing Pokémon from visual input.

3

NewLimit, co-founded by Brian Armstrong, raised $435M for epigenetic reprogramming and plans to enter human clinical trials next year, aiming to reverse cellular age without changing cell type.

4

SpaceX's AI1 satellite and Gigasat factory signal a shift where AI infrastructure becomes a launch and manufacturing problem, with Morgan Stanley projecting SpaceX revenue could hit $3.4 trillion by 2040.

Protocols

Concrete recipes — what, when, how much, and why

6 items

Coinbase AI Agent Wallet Setup

WhatUse Base protocol's self-custodial wallet to give AI agents their own financial accounts for autonomous transactions without KYC.
WhenWhen building or deploying AI agents that need to transact autonomously.
For whomDevelopers building AI agent systems, businesses wanting to accept AI agent customers.
WhyAI agents cannot get credit cards or pass traditional KYC; crypto wallets provide programmable, instant, global settlement.
CaveatsLiability questions unresolved—agent actions may roll up to the human or company controlling them. Legal precedent not yet established.

Armstrong outlined three phases: (1) connect LLMs to human Coinbase accounts via MCP API; (2) embed agentic interface (Coinbase Advisor) in-app; (3) give every AI agent its own financial account. The third phase is scaling now with ~100M transactions. He envisions on-chain reputation systems—like a FICO score or Yelp rating—to reduce fraud, where transaction graphs assign reputation scores based on counterparty quality. This could enable agents to assess merchant reliability before transacting.

Mechanism

Self-custodial wallets on Base protocol allow instant signup with no identity verification. Transactions settle on-chain using stablecoins like USDC in under one second for less than one cent, globally.

We have like a self-custodial wallet that any AI agent can sign up for instantly with no KYC they can have their own self-custodial wallet and that's what they're using to and transact right now.

Also said
“You can now send USDC for instance in under one second anywhere in the world for less than a cent US.”— Specifies the speed and cost advantage over traditional rails.
“One way you can do that is actually have a reputation on chain. This is something that we're hoping to build out over time.”— Introduces the fraud-prevention mechanism being developed.

NewLimit Epigenetic Reprogramming Pipeline

WhatAI-driven high-throughput screening of protein combinations to reprogram cells to a younger functional state without changing cell type.
WhenResearch stage; human clinical trials expected to begin next year.
For whomCurrently in development; eventual target is age-related functional decline.
WhyRestoring youthful cellular function could reverse age-related decline across tissues—liver, muscle, immune system, cognition.
CaveatsFDA approval is the slow part. Epigenetic clocks are unreliable biomarkers—morning vs. night readings differ. Functional assays (e.g., liver processing caffeine) are more meaningful.

Armstrong explained the pipeline stages: AI recommendation → pooled screens → functional assays → non-human primate trials → human trials. The process has gone faster than expected because AI accelerates the search space exploration. The $435M raise funds multiple concurrent trials—phase 1 at $10-20M each, scaling up. Armstrong noted the line between disease prevention and enhancement is blurry (e.g., preventing osteoporosis = stronger bones = enhancement), suggesting the technology will start with disease and expand.

Mechanism

Based on Yamanaka's 2012 Nobel-winning discovery that four proteins can reprogram old cells to embryonic stem cells. NewLimit aims to do 'half'—change age without changing cell type. AI explores 10 quadrillion protein combinations, ingesting literature and wet lab data. Pooled screens identify phenotypically younger cells; functional assays test if they act younger (e.g., metabolizing drugs). Best candidates advance to primate and human trials.

Personal experience

Armstrong: 'I thought this was going to be like a 5 or 10 year kind of basic research endeavor, but we've actually been able to demonstrate successful reprogramming of human cells now.' Peter Diamandis disclosed he is an investor in NewLimit.

At New Limit we're trying to do half of what Shiny Yamanaka did. We don't want to change the type of the cell we just want to change the age.

Also said
“We built a high throughput screening system. It starts with AI to explore the you know 10 quadrillion different possibilities and combinations of different proteins you could use to reprogram a cell.”— Explains the AI-driven discovery approach.
“We might take a reprogrammed liver cell and see if it can process caffeine and acetaminophen and alcohol or whatever kind of like a young a young liver cell.”— Gives a concrete example of functional assay.

Bitcoin Quantum Resistance Upgrade (BIP 360)

WhatProposal to upgrade Bitcoin's cryptography to post-quantum resistant algorithms before quantum computers can break current signatures.
WhenNo hard date set; advisory council is building community consensus. Not imminent but considered inevitable.
For whomBitcoin core developers, node operators, exchanges, and self-custody holders.
WhyA sufficiently powerful quantum computer could derive private keys from early Bitcoin addresses using older signature schemes, potentially seizing 5-10% of all Bitcoin including Satoshi's coins.
CaveatsWould increase block size (contentious in Bitcoin community). Key debate: freeze non-upgraded coins (Option A) vs. preserve seizure-resistance guarantee and let them be a 'bounty' (Option B). A hybrid with appeal mechanism is emerging. Self-custody holders must actively upgrade.

Armstrong detailed the contentious debate: Option A freezes coins that don't upgrade by a deadline—like 'a ship full of gold sinking to the bottom of the ocean'—preventing a quantum attacker from dumping them and crashing the price. Option B preserves Bitcoin's fundamental guarantee that wealth cannot be seized, treating the vulnerable coins as a bounty. A third hybrid option would freeze coins but allow an appeal process for rightful owners. Coinbase's quantum advisory council includes Dan Boneh (Stanford), Scott Aaronson (UT Austin), Justin Drake (Ethereum Foundation), and Yehuda Lindell (Coinbase). Armstrong noted this isn't just a Bitcoin issue—all internet cryptography faces the same threat.

Mechanism

Post-quantum cryptography replaces current elliptic curve signatures with algorithms resistant to Shor's algorithm on quantum computers. BIP 360 specifies how to implement this in Bitcoin's blockchain.

We don't think there's an imminent risk, but we do think that it's almost certain at this point that somebody eventually will create a powerful enough quantum computer that this challenges the cryptography in the current Bitcoin implementation.

Also said
“One school of thought would be to say, okay, tell everyone who owns Bitcoin by a certain date you all need to upgrade to this new algorithm... And any and then if it goes past the deadline, those coins would be frozen under option A.”— Explains the freeze option.
“Option B would be to say you know what this is a fundamental guarantee of Bitcoin is that your wealth can never be seized from you and we it's actually worth preserving that even if some bad person is able to go out there and go grab some of these coins.”— Explains the competing philosophical position.

Longevity Escape Velocity (LEV) Monitoring via Functional Assays

WhatTrack functional age reversal (cognition, muscle, immune, liver function) rather than epigenetic clock biomarkers to determine when LEV is achieved.
WhenOngoing; the $101M Healthspan Prize is measuring functional reversal of age.
For whomResearchers and clinicians evaluating longevity interventions.
WhyEpigenetic clocks give different readings morning vs. night and are unreliable. Functional measures—can you process drugs, think, move like you did 20 years younger—are more meaningful.
CaveatsLEV may be 'spiky' like AGI—achieved in subpopulations without broader notice. We won't know definitively for a long time because people won't be dying.

Alex argued LEV might be achieved this year in a 'spiky' way, citing a recent double-blinded study showing GLP-1s producing double-digit age reversal on epigenetic clocks in HIV patients. Peter countered that biomarkers are unreliable and functional measures matter more. The group compared it to the Turing test—we may pass LEV without society noticing. Armstrong predicted 2033 (Kurzweil's estimate) is plausible but FDA approval is the bottleneck. Dave noted 'the baby that's going to live to a thousand years old is already alive.'

What I care about is less a number on a page, but more functional. Do you have the ability to process liver function that you did earlier in life? Do you have the cognition, the immune, the muscle that you had 20 years younger?

Also said
“I think LEV is going to be spiky in the same sense that AGI is spiky and that on certain spikes it seems possible it might be achieved later this year.”— Alex's contrarian near-term prediction.
“The baby that's going to live to a thousand years old is already alive and that just blows your mind.”— Memorable framing of the stakes.

Embryo Gene Editing for Disease Prevention

WhatBase editing of embryos to correct disease-causing genes (e.g., PCSK9 for cholesterol, HBG for hemoglobin) before birth.
WhenResearch stage; Columbia University successfully demonstrated in vitro. Clinical application timeline unclear.
For whomFamilies with hereditary disease risk; eventually potentially for enhancement traits.
WhyPrevents hereditary diseases at the genetic level. 80% of Americans support embryo editing for disease prevention per Pew Research.
CaveatsJurisdiction shopping inevitable—parents will travel to permissive countries. Line between disease prevention and enhancement is blurry (osteoporosis prevention = stronger bones = enhancement). Eugenics concerns. Governance frameworks don't exist yet.

The hosts debated ethics and inevitability. Armstrong noted jurisdiction is the biggest complexity—local bans won't work because people will travel. He argued the disease/enhancement line is impossibly blurry and predicted we'll start with disease and expand to IQ and other traits. Alex compared it to Gattaca but noted base editing goes beyond embryo selection—it's 'better than the best of the parents.' Salim framed it as biology becoming a 'digital programmable domain' where 50 trillion cells per human is now a software engineering problem. The group noted IVF was once considered immoral but is now mainstream—suggesting norms will shift.

Mechanism

Base editing (invented by David Liu at Harvard) enables single nucleotide swaps in DNA with minimal error rates, superior to first-generation CRISPR. Performed on embryos in vitro before implantation.

Personal experience

Peter: 'My son Dax just did a project on this at school and his point was we give our kids the best food, the best education, the best friends, the best clothing. Why not start with the best genes?'

I think this is going to happen, too. I think it'll be good for humanity on net. I think a lot of people will freak out about it for a while.

Also said
“The line between disease prevention and enhancement... I basically think the line is so blurry that people will start with this for disease prevention and then it'll upgrade over time.”— Armstrong's prediction about the slippery slope.
“If you're 7 foot tall or higher, you have a 50% chance of making the NBA. And if you make the NBA, that's a $20 million a year paycheck.”— Concrete economic incentive that will drive adoption.

Apple Siri Rebuild with Google Gemini

WhatApple is rebuilding Siri as an agent with personal context, powered by Google Gemini AI under a multi-year partnership.
WhenBeta later this year, English-first.
For whomiPhone users; eventually all Apple ecosystem users.
WhyApple admitted it lost the foundation model race and chose to rent rather than build. The real moat is personal context—reasoning across messages, emails, notes, photos.
CaveatsCurrently requires Google's cloud compute—too intensive for on-device. Not announced for China or EU yet (will need local partners). Apple outsourcing core tech is unprecedented culturally.

Alex offered three perspectives: (1) glass half empty—Apple outsourcing core tech is unprecedented and culturally dissonant; (2) foundation models are like search engines—intrinsically localizable, so Apple will partner with different providers by region (Baidu in China, etc.); (3) hyperdeflationary economics mean any loss of sovereignty is temporary—in 1-2 years, these capabilities will fit on-device. Dave warned that losing the interface (Siri → Google → Android) while simultaneously losing chip manufacturing priority at TSMC to AI data center customers could create an existential threat to iPhone revenue. The hosts were skeptical given Siri's history of disappointment.

Mechanism

Gemini provides the foundation model; Apple provides personal context layer. Over time, hyperdeflation in compute costs should allow distillation to on-device inference.

Personal experience

Peter: 'I met the founders of Siri before they sold to Apple. It had such promise back then and it just stuck around just way too long.'

Apple is essentially admitting it lost the Frontier model or the foundation model race and chose Google to rent brains rather than build its own.

Also said
“If you buy that foundation model economics are hyperdeflationary and the cost is going down by 40x year-over-year... then you should view this entire bit of Apple losing its tech sovereignty as a nothing burger.”— Alex's third perspective on why this may not matter long-term.

What's new

Personal practice updates, fresh positions, predictions

6 items

Coinbase Agent Economy Transactions Surge

mid-episode, agent economy segment

AI agents are autonomously transacting on Coinbase's Base protocol using self-custodial wallets, with transaction volume growing from ~1M to ~100M transactions and ~$50M in value.

Why this matters: This validates the thesis that AI agents need programmable, non-KYC financial rails, and the scale is accelerating faster than publicly reported numbers suggest.

Background

Previously, AI agents were effectively 'unbanked' because they cannot pass traditional KYC checks or get credit cards. Coinbase created a self-custodial wallet on Base that any agent can sign up for instantly.

Brian Armstrong broke down the agent economy into three phases: (1) connecting LLMs like ChatGPT to human Coinbase accounts via MCP API for context and control; (2) embedding an agentic interface (Coinbase Advisor) directly in the app for portfolio rebalancing and tax-loss harvesting; (3) giving every AI agent its own financial account. The third phase is what's scaling now. Armstrong sees a future where agents orchestrate hundreds of other agents, requiring an 'agent payroll' system. He subscribes to the 'polytheist' view of AI—many specialized agents communicating and transacting—rather than a single AGI. This agentic economy, he argues, will eventually dwarf the human economy.

I think it's about 100 million transactions now maybe 50 million of value. So it's it's growing quickly.

Also said
“Every AI agent is going to have its own financial account, right? and it has to be able to sign up for that without you know going through a traditional process of like KYC know your customer like the an agent doesn't have a piece of paper issued by the government with your photo on it.”— Explains the core problem Coinbase is solving for agents.
“I think actually like stablecoin payments will probably be the the default layer for the agentic economy.”— Specifies the payment rail he expects to dominate.

Anthropic Fable 5 and Mythos 5 Launch

final segment, Anthropic story

Anthropic released two new frontier models: Mythos 5 (less inhibited) and Fable 5 (same model with added safety guardrails), retaking the lead from OpenAI across most benchmarks.

Why this matters: The release demonstrates a new strategy of bifurcating safety and performance into separately branded models, and shows long-range reasoning capabilities (e.g., playing Pokémon from visual input) not previously seen.

Background

Until this release, GPT-5.5 held the lead on most benchmarks. Anthropic had reportedly been holding this model back for safety testing, then released it after OpenAI pushed their latest.

Alex noted that the model can oneshot complex tasks like building a cyberpunk FPS game with no errors and a soundtrack. More impressively, it can play and win Pokémon games purely from visual reasoning—requiring long-range planning. The hosts observed that Anthropic doubled the price, countering the 'commodity intelligence' narrative. The safety split is stark: Fable 5 will refuse and downgrade to Opus on biology/chemistry topics with broad buffers, while Mythos 5 is less restricted. Alex speculated Anthropic is aggressively using RLVR (reinforcement learning with verifiable rewards) on long-range reasoning challenges involving spatial reasoning, large codebases, and CTF hunts. The hosts predicted the rate of model releases will accelerate as both Anthropic and OpenAI race toward their IPOs.

Personal experience

Dave noted he'd been using it for 4 hours since release: 'What it produces is so incredibly intelligent that it takes you quite a while to read and understand what it did.' Alex tested it with his favorite eval—oneshotting a cyberpunk FPS—and it 'did an amazing job, no errors, ran immediately, had a nice soundtrack.'

Very impressive release. Anthropic is back in the lead now.

Also said
“It's able to based on just watching the screens of games like various Pokémon games it's able to win them and that requires long-term long range reasoning capabilities that we really haven't seen until now.”— Highlights the novel long-range reasoning capability.
“They doubled the price, so it's expensive as all hell. This this idea of commodity intelligence is not happening.”— Counters the narrative that AI intelligence is becoming cheap and commoditized.

NewLimit Epigenetic Reprogramming Progress

longevity segment, NewLimit discussion

NewLimit has demonstrated successful reprogramming of human cells and plans to enter human clinical trials next year, using AI-driven high-throughput screening to discover protein combinations that reverse cellular age.

Why this matters: A $435M raise and imminent clinical trials mark a transition from basic research to applied age-reversal therapeutics, faster than Armstrong expected.

Background

Shinya Yamanaka won the 2012 Nobel Prize for reprogramming old skin cells into embryonic stem cells using four proteins, changing both age and cell type. NewLimit aims to do 'half' of that—changing only age, restoring youthful function without altering cell identity.

Armstrong explained the pipeline: AI ingests all existing literature and NewLimit's own wet lab data (the largest dataset in the field) to explore 10 quadrillion protein combinations. The AI recommends experiments; pooled screens identify candidates that make cells look phenotypically younger; functional assays then test if they act younger (e.g., reprogrammed liver cells processing caffeine and acetaminophen). The best candidates move to non-human primate and human trials. Armstrong initially thought this would be a 5-10 year basic research endeavor, but the AI-accelerated process has compressed timelines dramatically. The $435M will fund multiple clinical trials—phase 1 trials costing $10-20M each, scaling up through phases 2 and 3.

Personal experience

Armstrong recounted the origin: after Coinbase's IPO in 2021, he looked for underfunded moonshots, hosted dinners with scientists, and epigenetic reprogramming emerged as the most exciting underfunded area. He and Blake put in the first $100M.

We've actually been able to demonstrate successful reprogramming of human cells now in our first drug candidates going into the clinic next year, hopefully followed by a bunch more.

Also said
“At New Limit we're trying to do half of what Shiny Yamanaka did. We don't want to change the type of the cell we just want to change the age.”— Clarifies the core scientific approach.
“The process has gone faster than I would have expected. I thought this was going to be like a 5 or 10 year kind of basic research endeavor.”— Shows AI acceleration surprised even the founder.

SpaceX AI1 Satellite and Dyson Swarm

mid-episode, SpaceX AI1 satellite story

SpaceX unveiled the AI1 satellite—a 2-ton, 70m wingspan orbital compute node with 150 kW peak compute—designed as the first generation of a Dyson swarm, with a Gigasat factory planned in Texas for late 2027 production.

Why this matters: This shifts AI infrastructure from a real estate problem to a launch and manufacturing problem, with vertical integration enabling off-Earth manufacturing on the Moon.

Background

Previously, orbital compute was not on anyone's roadmap. SpaceX filed for 500,000 then 1 million satellites. The AI1 is simpler than Starlink satellites—mostly solar cells with laser links, no complex antennas.

Alex noted the form factor is dominated by solar arrays and radiators, with compute being a tiny fraction of surface area—suggesting massive room for improvement as compact fusion or power beaming matures. He called this 'the most disjointed, largest, bulkiest, most mainframe era node in the Dyson swarm we're ever likely to see.' SpaceX also released concept videos of manufacturing these on the Moon and launching them via electromagnetic railgun, which is why vertical integration matters—you can't do lunar manufacturing without controlling the full supply chain. The Gigasat factory will be 1,000 acres with 11 million square feet of facilities, producing everything from solar ingots to finished satellites on one campus. Armstrong noted the design must have redundancy for micrometeorite hits on radiators and solar panels, and speculated on how it folds into Starship's payload bay.

The AI satellite is essentially a lot of solar cells. You still need some laser links, but you don't have all the super complex antennas that you have on a Starlink satellite.

Also said
“If you have vertical integration of the solar and the compute, then you can do that on the moon and then your delta V is far more favorable and you can just start slinging these things out and building the actual Dyson swarm.”— Connects vertical integration to off-Earth manufacturing strategy.
“This is the first generation of I think the node in our Dyson swarm. Elon does over and over again, right? his Merlin engines, V1, V2, V3, they get smaller, more compact, get it working and then simplify.”— Frames this as an iterative hardware play following the SpaceX playbook.

Google Renting SpaceX AI Compute for $11B/Year

mid-episode, Google-SpaceX deal story

Google is paying SpaceX $11 billion per year through 2029 to access 110,000 NVIDIA GPUs in XAI's data center, signaling an extreme AI compute shortage and establishing SpaceX AI as a hyperscaler.

Why this matters: Google, which has its own TPUs and data centers, paying a competitor for GPU access at this scale indicates the compute bottleneck has completely shifted from model design to infrastructure.

Background

SpaceX AI previously rented compute to Anthropic. The Google deal is a three-year contract, month-to-month cancellable. This one deal halved SpaceX's IPO revenue multiple from 100x to 50x.

Alex speculated that Elon may be putting Grok on 'de facto life support' to focus on becoming a hyperscaler first, accumulating revenue to eventually build the Dyson swarm and then buy his way back to the frontier with superior compute. He noted that algorithmic wars may burn out as recursive self-improvement discovers optimal model architectures, shifting competition entirely to who has the most hardware. The hosts debated whether Elon will maintain partnerships long-term—Peter predicted he won't, based on historical pattern. The duopoly of Dario (Anthropic) providing the smartest AI and Elon providing space-based data centers and manufacturing could be incredibly powerful if it holds, but the partnership is likely temporary.

It's crazy that with one deal, SpaceX IPO went from 100x revenues to 50x revenues.

Also said
“If Google needs this much external compute like at this scale that tells you the bottleneck has completely shifted from model design to infrastructure.”— Diagnoses the strategic implication of the deal.
“I suspect the thinking may be become a hyperscaler for the moment. Put Grock on de facto life support for a year or two.”— Alex's theory on Elon's strategy.

US Government Exploring AI Company Equity Stakes

mid-episode, government equity story

Trump floated government ownership stakes in AI giants as 'a beautiful thing,' with precedent of 10% stakes in 20+ private companies; Bernie Sanders proposed 50% equity transfer to a public fund.

Why this matters: The Overton window on AI wealth distribution has shifted dramatically—this conversation was unthinkable 5 years ago.

Background

The US government already holds stakes in Intel (10%), MP Materials (15%), Lithium Americas (10%), and others. Trump's first executive orders included exploring a sovereign wealth fund.

Dave argued this is a 'horrible, horrible thing' long-term—while these specific investments may be good during an AI race with China, it sets a precedent for government capital allocation that future administrations will abuse. Alex countered that if AI companies become larger than the rest of the economy combined, some form of quasi-nationalization is inevitable. He suggested a scenario where the Treasury takes 5-10% golden shares in OpenAI and Anthropic, then gradually liquidates into an S&P 500 index to fund a sovereign wealth fund—effectively creating a universal basic dividend. Brian Armstrong was skeptical of government capital management, preferring policy-setting to equity ownership, but acknowledged a sovereign wealth fund could increase social cohesion if every citizen got a share at birth. He worried about politicization of investment decisions.

I think the government should be limited to setting policy and the private sector should do the capital allocation.

Also said
“If you put in place a precedent of the federal government choosing what to invest in in the private economy, you may love it for a little while, but there's an administration coming eventually that you won't love.”— Dave's core warning about the precedent.
“If OpenAI and Anthropic as the deacto duopoly that we have right now, if they're larger than the rest of the American economy combined, it's difficult to imagine a case... where there isn't some strong formal arrangement between those companies and the US government.”— Alex's argument for inevitability of some government arrangement.

Recommendations

Products, supplements, and tools mentioned in the episode

2 items

Anthropic Claude (Fable 5 / Mythos 5)

Tool

Anthropic's latest frontier models retake the lead across most benchmarks. Fable 5 is the safety-guardrailed version; Mythos 5 is less inhibited. Capable of long-range reasoning, oneshotting complex coding projects, and playing games from visual input.

Alex tested it with his benchmark eval—oneshotting a cyberpunk FPS—and it produced a visually stunning game with no errors and a soundtrack. More impressively, it can play and win Pokémon games from pure visual reasoning, demonstrating long-range planning previously unseen. Dave noted the output is so intelligent it takes time to read and understand what it did. The model doubled in price, countering commodity intelligence narratives. Fable 5 has broad safety buffers—it will downgrade to Opus on biology/chemistry topics it deems potentially dangerous. The hosts predict release cadence will accelerate as Anthropic and OpenAI race toward IPOs.

vs alternatives

Vs. GPT-5.5: Anthropic now leads on most benchmarks. Vs. Fable 5: Mythos 5 is less inhibited for sensitive topics. Vs. open source models: 99% cheaper for inference but 3-6 months behind in capability.

Personal experience

Dave: 'I've been playing for 4 hours... What it produces is so incredibly intelligent that it takes you quite a while to read and understand what it did.' Alex: 'Did an amazing job, no errors, ran immediately, had a nice soundtrack that came with it.'

Anthropic is back in the lead now.

Also said
“It's able to based on just watching the screens of games like various Pokémon games it's able to win them and that requires long-term long range reasoning capabilities that we really haven't seen until now.”— Demonstrates novel capability.
Find Anthropic

GLP-1 Receptor Agonists (e.g., Retatrutide)

Supplement

Alex cited a recent double-blinded study showing GLP-1s producing double-digit age reversal on epigenetic clocks in HIV patients, suggesting they may be among the first effective longevity drugs.

Alex argued this could mean we're achieving 'spiky' longevity escape velocity without broader notice—similar to how AGI passed the Turing test without fanfare. Peter agreed GLP-1s are 'probably one of the very first longevity drugs out there' but cautioned that epigenetic clocks are unreliable (different readings morning vs. night). He emphasized functional measures over biomarker numbers. Armstrong noted FDA approval is the bottleneck—the AI science moves fast but trials are slow.

vs alternatives

Vs. other longevity interventions: GLP-1s have human clinical data showing measurable age reversal effects, while most longevity compounds lack this evidence.

For the first time, to my knowledge, in the literature, I'm starting to see evidence of some sort of measurable at least double-digit age reversal as a result of GLP1s.

Also said
“GLP-1 drugs are probably one of the very first longevity drugs out there.”— Peter's endorsement of the category.
Find GLP-1
Disclosed sponsorships4speaker disclosed

Coinbase Base Protocol for AI Agent Wallets

Service Sponsored · disclosed

For developers building AI agents that need to transact autonomously—agents can't get credit cards or pass KYC, but can sign up instantly for self-custodial crypto wallets on Base.

DisclosureBrian Armstrong is CEO of Coinbase.

Armstrong described three phases of Coinbase's AI strategy: connecting LLMs to human accounts via MCP API, embedding an agentic advisor in-app, and giving every AI agent its own financial account. The third phase is live with ~100M transactions. He envisions on-chain reputation systems to reduce fraud. The infrastructure is faster and cheaper than traditional rails—USDC settles in under one second for less than one cent globally. This enables the 'agentic economy' where agents orchestrate hundreds of other agents and need payment rails for 'AI agent payroll.'

vs alternatives

Vs. traditional bank accounts: no KYC required, instant settlement, global, programmable. Vs. other blockchains: Base offers Coinbase's ecosystem and on/off-ramps.

Make sure your business is ready to accept AI agents as customers.

Also said
“Stablecoin payments will probably be the the default layer for the agentic economy.”— Specifies which crypto rail he expects to dominate.
Find Coinbase

Fountain Life AI-Powered Health Screening

Service Sponsored · disclosed

AI-powered CT angiography with AI analytics detects coronary artery disease, including soft plaque not visible on traditional calcium scores. 88% of people coming in have detectable coronary artery disease; 23% have soft plaque requiring intervention.

DisclosurePeter Diamandis is founder of Fountain Life. This was a sponsored segment.

Dr. Don Mucalem, chief medical officer, shared her personal mission: her husband died of sudden cardiac death when their daughter was five. 50% of people who die of heart attacks have no warning signs—no shortness of breath, no pain. Fountain Life combines CT angiography with AI analytics, diagnostic laboratory studies, and healthy lifestyle recommendations for a multimodal approach to early detection and prevention.

vs alternatives

Vs. traditional calcium scoring: detects soft plaque that calcium scores miss. Vs. waiting for symptoms: 50% of heart attack deaths occur with no prior warning signs.

Personal experience

Dr. Mucalem: 'When my daughter was five, my husband died of sudden cardiac death. And so this is a topic that is one that I am mission-driven to try to eradicate.'

50% of people die of heart attacks with no warning signs. No shortness of breath, no pain, no nothing. They just don't wake up in the morning.

Also said
“88% of people coming in have detectable coronary artery disease. But what's more alarming to me is 23% of those individuals had soft plaque. This is the plaque that would not traditionally be seen on CT looking at calcium scores alone.”— Quantifies the detection gap Fountain Life addresses.
Find Fountain

Blitzy Autonomous Software Development Platform

Service Sponsored · disclosed

Blitzy uses thousands of specialized AI agents to understand enterprise-scale codebases with millions of lines of code, delivering 80%+ of development work autonomously while providing a guide for the final 20% of human work.

DisclosureThis was a sponsored segment.

Engineers start each sprint by bringing development requirements to Blitzy, which provides a plan, generates and pre-compiles code for each task. Enterprises report 5x engineering velocity increase when using Blitzy as a pre-IDE development tool paired with their coding copilot of choice. It functions as an AI-native SDLC integration.

vs alternatives

Vs. coding copilots alone: Blitzy operates pre-IDE with infinite code context across millions of lines, handling the planning and bulk generation before human developers finish the work.

Blitzy delivers 80% or more of the development work autonomously while providing a guide for the final 20% of human development work required to complete the sprint.

Find Blitzy

Long-Term Bitcoin Holding Strategy

Practice Sponsored · disclosed

Armstrong recommends taking a long-term perspective on Bitcoin, viewing short-term price movements as noise. He sees Bitcoin as 'digital gold' and believes by 2030 the price will be much higher.

DisclosureBrian Armstrong is CEO of Coinbase. Peter Diamandis disclosed he holds substantial Bitcoin.

Armstrong attributed recent price weakness to AI absorbing risk capital, stablecoins becoming the 'new meta' after the Genius Act, and Bitcoin's inflation-hedge trade losing excitement. He believes these are short-term effects and that Bitcoin has probably bottomed around $60K. He noted the four-year cycle pattern and predicted a positive direction by October, with $100-200K plausible by year-end. He acknowledged the 'countercyclical' thesis hasn't fully played out—only ~30% of capital treats Bitcoin as digital gold, while ~70% treats it as a risk asset—but expects the ratio to shift over time.

vs alternatives

Vs. gold: Bitcoin has much higher daily trading volume (~5% of supply vs. gold's ~5%), is more accessible, and has no custodial nightmares. Vs. trading: Armstrong advocates holding, not timing cycles.

Personal experience

Peter Diamandis: 'I bought my first Bitcoin in 2014 on Coinbase. I have a substantial amount of my personal net worth in Bitcoin and I'm holding it.' Brian Armstrong: 'I'm long Bitcoin just like always.'

It's never as good as it seems, never as bad as it seems with these things. You've got to take a long-term perspective.

Also said
“I think Bitcoin is the new digital gold. I think it's going to be a key part of our economy going forward into the future.”— Core investment thesis.
“My instinct is we've probably have bottomed at this point, maybe at the 60k number, but nobody can say for sure.”— Near-term market view.
Find Long-Term

Notable quotes

Lines worth pulling out — contrarian, specific, or perfectly phrased

6 items
It's never as good as it seems, never as bad as it seems with these things. You've got to take a long-term perspective.
Concise investing philosophy applicable beyond crypto, from a founder who's navigated extreme volatility.
I think the government should be limited to setting policy and the private sector should do the capital allocation.
Clear, principled stance on the government equity debate from a public company CEO.
The baby that's going to live to a thousand years old is already alive and that just blows your mind.
Striking framing of longevity escape velocity's implications—makes the abstract concrete.
This is the most disjointed, the largest, bulkiest, most mainframe era node in the Dyson swarm we're ever likely to see.
Vivid characterization of the AI1 satellite as a first-generation prototype with massive room for improvement.
We may crack death and Bitcoin is going to crack taxes. So, there you go.
Pithy summary connecting the episode's two major themes—longevity and crypto—into a single provocative claim.
If you're 7 foot tall or higher, you have a 50% chance of making the NBA. And if you make the NBA, that's a $20 million a year paycheck. So if you're a couple... you're going to go to that Caribbean island and make your seven foot tall for economic reasons.
Stark economic incentive argument for why embryo editing for enhancement is inevitable, regardless of regulations.

Sign in to share feedback

Tell us if this brief hit the mark or missed it — feedback feeds back into the next iteration of the prompt.

Topics covered

bitcoin-price-outlookbitcoin-as-digital-goldai-agent-economycrypto-payment-railsagentic-walletsstablecoinsbitcoin-quantum-riskpost-quantum-cryptographybip-360satoshi-coinsus-government-ai-equitysovereign-wealth-fundopenai-ipospacex-valuationspacex-ai1-satellitedyson-swarmgigasat-factorygoogle-spacex-compute-dealai-compute-shortageanthropic-fable-5
Free account

Make this library yours

Reading is free for everyone. A free account adds the personal layer: save protocols, follow experts, and see how the other experts weigh in on this same topic.

Create a free accountSign in

Where the experts disagree — weekly

One email a week: the sharpest new disagreements and protocols from the library. No spam, unsubscribe anytime.

Educational summary of the cited expert source — not medical advice. Open the source recording linked above and consult a qualified physician before acting on any protocol.